APOE and cerebral amyloid angiopathy: Further, apoE4 was demonstrated to disrupt Aβ clearance at the blood–brain barrier (BBB) in an isoform-dependent manner (ApoE4 > ApoE3 > ApoE2) and to promote cerebral amyloid angiopathy pathogenesis [47].